p16 Tumor Suppressor

作者: Ken McCormack , Alexander Kamb

DOI: 10.1007/978-1-59259-230-2_8

关键词: Kinase activityKinaseCell cycleCyclin-dependent kinaseCell biologyCell cycle checkpointCyclinChemistryTransition (genetics)Suppressor

摘要: p16, a protein named for its migration rate on denaturing gels, is member of class functionally similar proteins called cyclin-dependent kinase inhibitors (CDKI). p16 and relatives bind to CDKs inhibit their activity. Because cyclins form the core cell cycle apparatus, positioned directly regulate some most basic decisions. In eukaryotic cells, typically described in terms four component phases: G1, S, G2, M. Most regulation occurs at G1—S G2—M transitions. higher eukaryotes, G1 checkpoint especially important. This precisely where acts, activity biochemically linked other regulators transition, including wellknown regulator (and tumor suppressor protein), Rb.

参考文章(61)
S. N. Khleif, F. J. Kaye, Weidong Chen, A. B. Coxon, G. A. Otterson, CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene. ,vol. 11, pp. 1211- 1216 ,(1995)
Lisa A. Cannon-Albright, David E. Goldgar, John J. Zone, David E. Anderson, Mark H. Skolnick, Laurence J. Meyer, Cathryn M. Lewis, Marguerite Jost, William P. McWhorter, Deborah Harrison, Penetrance and Expressivity of the Chromosome 9p Melanoma Susceptibility Locus (MLM) Cancer Research. ,vol. 54, pp. 6041- 6044 ,(1994)
Alicia A. Russo, Lily Tong, Jie-Oh Lee, Philip D. Jeffrey, Nikola P. Pavletich, Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. ,vol. 395, pp. 237- 243 ,(1998) , 10.1038/26155
Priya Dayananth, Steven Stone, Alexander Kamb, Reversible, p16-mediated Cell Cycle Arrest as Protection from Chemotherapy Cancer Research. ,vol. 56, pp. 3199- 3202 ,(1996)
Ignacio Palmero, Cristina Pantoja, Manuel Serrano, p19ARF links the tumour suppressor p53 to Ras Nature. ,vol. 395, pp. 125- 126 ,(1998) , 10.1038/25870
Andreas von Deimling, Jimmy T. Efird, John W. Henson, David N. Louis, Yasuhiro Ono, Keisuke Ueki, CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Research. ,vol. 56, pp. 150- 153 ,(1996)
Sean V. Tavtigian, Harold Katcher, Priya Dayananth, Steven Stone, Ping Jiang, David Parry, Alexander Kamb, Gordon Peters, Complex Structure and Regulation of the P16 (MTS1) Locus Cancer Research. ,vol. 55, pp. 2988- 2994 ,(1995)
Bulyk Ml, Housman De, Glendening Jm, Castresana Js, Fountain Jw, Flores Jf, Hayward Nk, Haluska Fg, Kao Wh, Pastorfide Gc, Walker Gj, Boyer La, Barnhill Rl, Rubio Mp, Loss of the p16INK4a and p15INK4b Genes, as well as Neighboring 9p21 Markers, in Sporadic Melanoma Cancer Research. ,vol. 56, pp. 5023- 5032 ,(1996)
William D. Foulkes, Tamar Y. Flanders, Pamela M. Pollock, Nicholas K. Hayward, The CDKN2A (p16) gene and human cancer. Molecular Medicine. ,vol. 3, pp. 5- 20 ,(1997) , 10.1007/BF03401664